Market closed · After hours · 4:19 PM ET
Last update: Jul 1, 2026, 3:44 PM ETTEM
Tempus AI, Inc.$61.60▲ 6.34% todayAfter Hours
What happened
Earnings Beat
Tempe Inc. (TEM) rose 38.1% after reporting EPS of -$0.13, beating the consensus
- Tempe Inc. (TEM) rose 38.1% after reporting EPS of -$0.13, beating the
Material / EarningsCompany-Specific MoveWeak confidence
Rel. volume
1.4×
Normal
Vs peers
No peer data
In Line With Peers
Market cap
$10.8B
NASDAQ
Earnings in
44d
2026-08-14
Price chart
Jun 1 – Jul 1
E earnings
F filing
A analyst
V/N other
click a marker to highlightChange events — click to highlight on chart
Valuationtoday
reaction: +8.1%
Material / Earnings57d ago
reaction: -3.1%
Filings40d ago
reaction: -0.7%
Valuation · 2026-07-01
TEM rose 6.37% to $61.62 on a Buy rating citing FDA approval for xT CDx's tumor-only indication and upcoming xH assay expansion for the AI diagnostics platform.
FDA approval timeline and commercial uptake data for the xH assay launch in 2026.
via fmp_intraday
Analyst expectations
Consensus target: $73+17.9%
= 5 maintains
Last: JP Morgan downgrade · 2025-02-25
SEC filings watch
Peer context
TEM+6.3%
TEM outperformed peers by more than expected sector variance — move appears company-specific.
Educational research tool — not personalized investment advice. Data may be delayed.